Automated Sample Preparation (For Genomic Applications) - A Global and Regional Analysis: Focus on Product, Application, End-User, and Region
Introduction of Automated Sample Preparation
The global automated sample preparation market was valued at $1,431.9 million in 2023 and is expected to reach $3,730.5 million by 2033, growing at a CAGR of 10.05% between 2023 and 2033. The growth of the automated sample preparation market is driven by the increasing demand for high-throughput and standardized sample processing, especially in industry such as genomics. As research and diagnostic requirements continue to evolve, the adoption of automated sample preparation solutions becomes essential for laboratories seeking to enhance their analytical workflows.
Market IntroductionThe automated sample preparation market refers to the industry involved in the development, manufacturing, and distribution of automated systems and technologies designed to streamline and enhance the process of preparing samples for scientific analysis. This market primarily caters to various industries such as life sciences, pharmaceuticals, biotechnology, environmental testing, food and beverage, and clinical diagnostics.
Sample preparation is a crucial step in many scientific workflows, where raw samples, such as biological tissues, environmental samples, or chemical substances, need to be processed and purified before analysis. Automation in sample preparation involves the use of advanced robotic systems, liquid handling platforms, and other automated instruments to increase efficiency, reduce human errors, and improve reproducibility in sample processing.
Industrial ImpactThe global automated sample preparation market is a dynamic and rapidly evolving sector and is witnessing double digit growth, driven by increasing requirements of advanced technology tools and processes to streamline and improve sample preparation for scientific research and analysis. The growing use of robotics, automation, and specialized instruments to eliminate manual handling errors is further expected to contribute to the growth.
Market Segmentation:Segmentation 1: by Product TypeKits and Consumables
Instruments
Kits and Consumables Segment to Dominate the Automated Sample Market (by Product Type)Based on product type, the global automated sample preparation market was led by kits and consumables segment, with a 67.47% share in 2022 primarily due to the convenience and reliability offered by these kits, which significantly streamline the workflow and ensure standardized and reproducible results. Researchers benefit from ease of use, as the pre-optimized components eliminate the need for extensive manual preparation, saving time and reducing the likelihood of errors. As the market continues to advance, the development of innovative kits and consumables remains crucial for driving progress in automated sample preparation technologies and their widespread adoption across scientific disciplines.
Segmentation 2: by ApplicationResearch and Development
Diagnostics
Research and Development to Witness the Highest Growth between 2023 and 2033The research and development segment holds the largest share in the automated sample preparation market for several compelling reasons. The expansion of this application can be credited to the surge in research and development endeavors, coupled with a heightened demand for top-notch products. Automated liquid handlers find extensive use in laboratories, guaranteeing pristine hands during sample handling and minimizing the risk of cross-contamination from preceding batches.
Segmentation 3: by End UserBiotechnology and Pharmaceutical Companies
Clinical and Diagnostic Laboratories
Academic and Research Institutions
Biotechnology and Pharmaceutical Companies Segment to Witness the Highest Growth between 2023 and 2033Biotechnology and pharmaceutical companies hold a significant share of the end user market in the global automated sample preparation market for several reasons. Ongoing research endeavors in the pharmaceutical and biotechnology industries place significant emphasis on the introduction of novel technologies to the market. In this context, automated sample preparation techniques play a crucial role in facilitating swift analysis and delivering precise results when dealing with diverse and multiple samples.
Segmentation 4: by RegionNorth America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest-of-Europe
Asia-Pacific
Japan
India
China
South Korea
Australia
Rest-of-Asia-Pacific
Latin America
Brazil
Mexico
Rest-of-Latin America
Middle East and Africa
Recent Developments in the Automated Sample Preparation MarketIn November 2023, QIAGEN N.V. expanded its sample technologies portfolio by introducing several products designed to assist researchers in handling various materials like bone, tissue, and soil samples. For instance, TissueLyser III, a high-throughput instrument that enhances and diversifies the disruption of various biological samples containing nucleic acids (DNA and RNA).
In July 2023, MGI Tech Co., Ltd., a company dedicated to being a top innovator in life science, released its improved automated sample preparation system called MGISP-Smart 8. It's a smart and advanced 8-channel pipetting robot designed to make molecular diagnosis and high-throughput sequencing even easier with its flexibility and user-friendly features.
In September 2022, Agilent Technologies, Inc. collaborated with METTLER TOLEDO to tackle a major concern in laboratories, which is error-prone sample preparation. Through this integrated solution, weighing results and the corresponding metadata from METTLER TOLEDO LabX Balance software can be automatically and seamlessly transferred to Agilent OpenLab software.
In August 2022, MGI Tech Co., Ltd. created a wide range of products that cover sample pre-processing, automated pipetting workspace, and automated nucleic acid extraction, with a strong emphasis on the R&D of laboratory automation products that are crucial tools for high-throughput gene sequencing and large-scale nucleic acid sensing.
Demand – Drivers, Challenges, and Opportunities
Market Demand Drivers:Increasing Prevalence of Infectious Disease and Cancer Cases: The increasing prevalence of infectious diseases and cancer cases is driving a significant surge in the demand for automated sample preparation consumables and instruments. This growing demand is primarily due to the pivotal role that genetic analysis plays in the diagnosis, treatment, and monitoring of infectious diseases. For instance, according to the International Agency for Research on Cancer (IARC), the global cancer burden was estimated at 24.3 million new cases in 2020, with a worldwide five-year prevalence estimated at 50.6 million.
Market Challenges:Integration with the Current Laboratory Setup a Complex Process: While automation holds the potential for improved efficiency and innovation, integrating these advanced solutions seamlessly with current laboratory setups presents a significant challenge. Laboratories often house a diverse range of equipment, instruments, and data management systems, each with its own specifications and requirements. Compatibility issues, varying communication protocols, and the need for seamless interaction among different components contribute to the intricacy of the integration process. Furthermore, the potential risks associated with data management, security, and operational disruptions underscore the necessity for a comprehensive risk assessment.
Market Opportunities:Increasing Opportunity for Automated Systems in Developing Countries: The increasing adoption of automated systems in developing countries presents a notable opportunity within the automated sample preparation market. As technological advancements gain traction in these regions, laboratories are embracing automated processes to enhance their capabilities. This shift not only reflects a growing trend toward modernization but also opens up a new market for automated sample preparation solutions.
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The global automated sample preparation market has been segmented based on various categories, such as product type, application, end user, and region.
Growth/Marketing Strategy: Product launches and upgradations and synergistic activities together accounted for the maximum number of key developments, at nearly 88.24% of the total developments in the automated sample preparation market between January 2021 and December 2023.
Competitive Strategy: The global automated sample preparation market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the automated sample preparation market analyzed and profiled in the study involve established players that offer various kinds of products and services.
MethodologyKey Considerations and Assumptions in Market Engineering and ValidationThe base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2033.
The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of clinical biomarkers.
The market contribution of automated sample preparation anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
The market has been mapped based on the available automated sample preparation solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.
Primary Research:The primary sources involve industry experts in automated sample preparation, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:validation and triangulation of all the numbers and graphs
validation of the report’s segmentation and key qualitative findings
understanding the competitive landscape and business model
current and proposed production values of a product by market players
validation of the numbers of the different segments of the market in focus
percentage split of individual markets for regional analysis
Secondary ResearchOpen SourcesCertified publications, articles from recognized authors, white papers, directories, and major databases, among others.
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their product portfolio
Gold standard magazines, journals, white papers, press releases, and news articles
Paid databases
The key data points taken from the secondary sources include:segmentations and percentage shares
data for market value
key industry trends of the top players of the market
qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
quantitative data for mathematical and statistical calculations
Key Market Players and Competition SynopsisThe companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
The research and development application segment players leading the market captured around 69.58% of the market's presence as of 2022. Diagnostics application segment, on the other hand, accounted for approximately 30.42% of the market presence in 2022.
Some prominent names established in this market are:Agilent Technologies, Inc.
Aurora Biomed Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Metrohm AG
Mettler-Toledo International Inc
MGI Tech Co., Ltd.
Promega Corporation
QIAGEN N.V.
Raykol Group (XiaMen) Corp., Ltd.
Revvity, Inc.
SOTAX
Tecan Trading AG
Thermo Fisher Scientific Inc.
Waters Corporation
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.